TriSalus Life Sciences, Inc. TLSI Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $56.55M+324% | $20.79M+134% | $23.04M+97.9% | $26.84M+59.5% | $13.35M+209% | ||
| $22.34M+10.8% | $22.58M+18.9% | $21.12M+20.7% | $21.04M+34.5% | $20.17M+76.5% | ||
| $3.78M-9.2% | $3.08M-24.0% | $3.28M-18.1% | $3.81M+10.6% | $4.16M— | ||
| $68.14M+172% | $32.24M+56.0% | $33.33M+40.0% | $38.08M+36.3% | $25.1M+90.3% | ||
| $1.94M-1.3% | $1.81M+8.3% | $1.83M+0.4% | $1.71M-6.5% | $1.97M— | ||
| $70.98M+148% | $35.33M+47.4% | $36.46M+32.7% | $41.32M+27.4% | $28.63M+60.0% | ||
| $4.23M+50.8% | $3M+32.0% | $3.78M+162% | $1.9M-3.7% | $2.81M+19.5% | ||
| $11.79M+0.3% | $11.5M+12.4% | $10.91M+10.0% | $9.32M-22.3% | $11.75M-18.3% | ||
| $33.08M+4.4% | $33.05M— | $32.76M— | $32.27M— | $31.7M— | ||
| $58.17M-7.7% | $69.19M+38.8% | $63.19M+31.9% | $60.74M+7.4% | $63M+19.3% | ||
| 400M0.0% | 400M+13,333,233% | 400M0.0% | 400M0.0% | 400M— | ||
| -$329.04M-13.5% | -$330.58M-18.3% | -$320.97M-19.1% | -$298.21M-12.1% | -$289.92M-10.8% | ||
| $12.81M+137% | -$33.86M-30.8% | -$26.73M-30.8% | -$19.42M+23.1% | -$34.37M+4.6% | ||
| $70.98M+148% | $35.33M+47.4% | $36.46M+32.7% | $41.32M+27.4% | $28.63M+60.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are TriSalus Life Sciences, Inc.'s total assets?
- TriSalus Life Sciences, Inc. (TLSI) holds $71.0M in total assets, up 148.0% year over year.
- How much debt does TriSalus Life Sciences, Inc. have?
- TriSalus Life Sciences, Inc. carries $33.1M in total debt against $12.8M of shareholders' equity, a debt-to-equity ratio of 2.58.
- How much cash does TriSalus Life Sciences, Inc. have?
- TriSalus Life Sciences, Inc. holds $56.6M in cash and equivalents.
- Can TriSalus Life Sciences, Inc. cover its short-term obligations?
- Its current ratio is 5.78 — current assets exceed current liabilities.
- Where does TriSalus Life Sciences, Inc.'s balance sheet data come from?
- Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
